ncq 298 has been researched along with perphenazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freccero-Rosman, K; Levander, S; Ohlsson, T; Rosén, I; Ryding, E; Sjöholm, H; Tuninger, E | 1 |
1 other study(ies) available for ncq 298 and perphenazine
Article | Year |
---|---|
Dopamine D2-receptor density in humans as assessed with SPET and the new high-affinity ligand 123I-NCQ298: a pilot study.
Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebrovascular Circulation; Dopamine Agonists; Female; Haloperidol; Humans; Iodine Radioisotopes; Male; Middle Aged; Perphenazine; Pilot Projects; Radiopharmaceuticals; Receptors, Dopamine D2; Regional Blood Flow; Salicylamides; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1998 |